Ashland stock
ASHNYSEAshland Inc., Basic MaterialsISIN US0441861046
53Score 53 out of 100, Neutral
Price and trend
87 / 100
Price history
+50% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 17% above it.
Since June 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 59).
The price is 3.1% below its 52-week high. Largest decline in 20 years: 92% (December 2006 to March 2009).
Chart figures for advanced users
- SMA 50$71.81
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$64.33
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)59
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$48.18
- The lowest closing price of the last twelve months.
- Resistance$77.70
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Ashland Inc. belongs to the Chemicals (Specialty) industry (United States) and, with a market value of $3.45B, is number 73 of 108 companies in its industry on MEQIRI.
- For fiscal 2027, analysts expect on average revenue of $1.94B (up 3.9%) and adjusted earnings per share of $4.28 (up 29.4%).
- MEQIRI Score 53 out of 100 (Neutral): rank 290 of 467 in Basic Materials, median 58.
Show more
- The P/E is 138.5 (Chemicals (Specialty) median 24.4, own median of recent years 24.3).
- Our model puts fair value at $53.24, with the price 44% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Share buybacksShare count down 25% since 2021.Capital allocation 61
- Reliable dividendNo dividend cut for 17 years.Capital allocation 61
- Analysts expect strong earnings growthUp 16% a year through 2029 (estimates from 6 analysts).
Weaknesses
- Richly valuedP/E 138.5, Chemicals (Specialty) median 24.4, own median 24.3.Valuation 28
- Margin fallingOperating margin 5.6%, average of the prior years 7.9% (to 2025).Profitability 33
- Revenue shrinkingRevenue down 2.5% a year since 2021.Growth 26
Its standout strengths are momentum and technical analysis, while valuation and growth hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 54 to 53.
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among smaller stocks.
From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- cyclical sector (energy or materials), as a group, crashed more often in the backtest
What lowers it
- price near its 52-week high
- stable momentum
Valuation
Valuation signal
Modestly overvaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $38.03 and expensive above $88.73 (uncertainty high, one part of the fair value is more than twice the other).
The two parts of the fair value come to $93.24 (cash-flow model) and $13.23 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $44.89, at 7.8% it would be $65.81.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (24.4).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In fiscal 2026, revenue rose 2.1% on the prior year. Revenue has declined since 2007 (-7% per year), so it is worth watching closely.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2026: gross 32%, operating 6%, net not measured.
Debt & balance sheet
latest quarterDebt is moderate, but interest coverage is weak. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 1 Feb 2027in 81 days
- Last reported
- 3 Nov 2026EPS reported $1.12 (expected $1.27)below expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $4.28+0.1%
- Revenue
- $1.94B+0.3%
- Earnings per share
- $5.00+2.4%
- Revenue
- $2.02B+0.8%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: +6.9%Fiscal 2026 sales and adjusted EBITDA guidance reaffirmed, with higher profitability expected in the fourth quarter.
“As a result, we are reaffirming our fiscal 26 sales and adjusted EBITDA guidance.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 29 Jul 2026 (fiscal Q3 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases or sales in the last 6 months.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Ashland
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 53
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Wacker ChemieWCH.DE $4.57B46
- ClariantCLN.SW $4.41B61
- AvientAVNT $4.24B61
- CabotCBT $3.71B61
- HEXPOLHPOL-B.ST $3.31B68
- Azelis GroupAZE.BR $3.18B59
- HawkinsHWKN $3.16B69
- CalumetCLMT $3.15B47
ETFs that hold Ashland
Held by 14 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Avantis Global Small Cap Value UCITS ETFAVWS | 0.22% | 0.39% | €1.47B |
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.12% | 0.30% | €2.17B |
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.12% | 0.30% | €4.22B |
Show 5 more
| L&G Russell 2000 US Small Cap Quality UCITS ETFETLZ | 0.12% | 0.30% | €185.82M |
| State Street SPDR S&P 400 U.S. Mid Cap UCITS ETF (Acc)SPY4 | 0.10% | 0.30% | €5.27B |
| State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV | 0.09% | 0.30% | €944.34M |
| State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc)SPYI | 0.05% | 0.17% | €8.6B |
| State Street SPDR MSCI World Small Cap UCITS ETF (Acc)ZPRS | 0.04% | 0.45% | €1.53B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 30 Sep 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 31 Jul 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.